8-Fluoroimidazo[1,2-a]pyridine, 95.0%, 5g

2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

4-Bromobenzene-1,3-diamine, 95.0%, 1g

4-hydroxy-N,N-dimethylbenzamide, 95.0%, 1g

4,6-DICHLORO-3-IODO-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 95%, 1g

Provette, 5 ml, Altezza, 50 mm, 100 Pezzo(i)

AZTAK1 INHIBITOR, 98.0%, 25mg

(S)-3-Ethylmorpholine hydrochloride, 95.0%, 1g

N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide, 95.0%, 25g

1-(2-BENZENESULFONYL-ETHYL)PIPERAZINE 2HCL, 95.0%, 100mg

(2R,2'R,3R,3'R)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 500mg

(2R,3S,4S,5R)-2,3,4,6-Tetrakis(benzyloxy)-5-hydroxyhexanal, 97%, 5g

Tributylsilane>98.0%(GC)25g